Article Text

Download PDFPDF
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)
  1. Philipp Harter, MD*,
  2. David Gershenson, MD, PhD,
  3. Catherine Lhomme, MD, PhD,
  4. Fabrice Lecuru, MD, PhD§,
  5. Jonathan Ledermann, MD, FRCP,
  6. Diane M. Provencher, MD, PhD,
  7. Delia Mezzanzanica, MD, PhD#,
  8. Michael Quinn, MD, PhD**,
  9. Johanna Maenpaa, MD, PhD,,
  10. Jae-Weon Kim, MD, PhD,,
  11. Sven Mahner, MD, PhD§§,
  12. Felix Hilpert, MD, PhD∥∥,
  13. Klaus Baumann, MD¶¶,
  14. Jacobus Pfisterer, MD, PhD## and
  15. Andreas du Bois, MD, PhD*
  1. *Kliniken-Essen-Mitte, AGO, Essen, Germany;
  2. MD Andersen Cancer Center, GOG, Houston, TX;
  3. Gustave Roussy, GINECO, Villejuif Cedex, France;
  4. §Université René Descartes, GINECO, Paris, France;
  5. UCL Cancer Institute, MRC NCRI, London, United Kingdom;
  6. CHUM–Notre-Dame Hospital, NCIC-CTG, Montreal, Quebec, Canada;
  7. #Fondazione IRCCS Istituto Nazionale dei Tumori, MITO, Milan, Italy;
  8. **ANZGOG, Parkville, Victoria, Australia;
  9. ††University and University Hospital of Tampere, NSGO, Tampere, Finland;
  10. ‡‡Seoul National University, KGOG, Seoul, South Korea;
  11. §§University Medical Center Hamburg-Eppendorf, AGO, Hamburg, Germany;
  12. ∥∥University Hospital Kiel, AGO, Kiel, Germany;
  13. ¶¶UKGM, Marburg, AGO, Marburg, Germany; and
  14. ##Gynecologic Oncology Center, Kiel, AGO, Kiel, Germany.
  1. Address correspondence and reprint requests to Dr Philipp Harter, Department of Gynecology and Gynecologic Oncology, Kliniken-Essen-Mitte, Henricistrasse 92, 45136 Essen, Germany. E-mail: p.harter{at}


Abstract Since the early 1970s, the World Health Organization and the International Federation of Gynecology and Obstetrics have classified borderline ovarian tumors as an independent group of ovarian epithelial tumors. A consensus statement of the Gynecologic Cancer Intergroup is reported.

  • Gynecologic Cancer InterGroup
  • GCIG
  • Ovarian tumor of low malignant potential
  • BOT

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interest.